Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

Mainz Biomed (MYNZ)

  • Technical Exchange News
  • Jan. 15, 2025, 19:07 UTC
  • 71
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Syros Pharmaceuticals (SYRS)

  • Technical Exchange News
  • Jan. 15, 2025, 02:39 UTC
  • 61
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Syros Pharmaceuticals (SYRS)

  • Technical Exchange News
  • Jan. 14, 2025, 19:17 UTC
  • 60
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

TC BioPharm Holdings (TCBP)

  • Technical Exchange News
  • Jan. 14, 2025, 02:50 UTC
  • 73
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

ProMIS Neurosciences Inc (PMN)

  • Technical Exchange News
  • Jan. 14, 2025, 02:50 UTC
  • 62
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Lexicon Pharmaceuticals Inc. (LXRX)

  • Technical Exchange News
  • Jan. 14, 2025, 02:49 UTC
  • 62
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Incannex Healthcare Ltd (IXHL)

  • Technical Exchange News
  • Jan. 14, 2025, 02:49 UTC
  • 64
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

TC BioPharm Holdings (TCBP)

  • Technical Exchange News
  • Jan. 13, 2025, 19:25 UTC
  • 63
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

ProMIS Neurosciences Inc (PMN)

  • Technical Exchange News
  • Jan. 13, 2025, 19:25 UTC
  • 59
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Lexicon Pharmaceuticals Inc. (LXRX)

  • Technical Exchange News
  • Jan. 13, 2025, 19:24 UTC
  • 65
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text
  • Previous
  • 628
  • 629
  • 630
  • 631
  • 632
  • Next

Search

News categories

  • Technical Exchange News(14411)
  • Event(6229)
  • SEC News(376168)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(230065)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin